- New
7.2mg Numelvi Tablets for Dogs - Per Tablet
965285
7.2mg Numelvi Tablets are prescription tablets for dogs that need help managing allergic skin disease. The active ingredient is atinvicitinib, a targeted Janus kinase inhibitor used to treat pruritus (itchiness) associated with allergic dermatitis and the clinical signs of atopic dermatitis.
Allergic dermatitis is a broad clinical term for inflammation and itch caused by an abnormal reaction to something in, on or around the dog. That trigger might be flea saliva, food ingredients, environmental allergens, contact irritants or a combination of factors. Atopic dermatitis is one of the most common forms of allergic dermatitis, and it is usually a chronic, relapsing condition linked to allergens such as pollen, moulds and house dust mites.
Dogs with atopic dermatitis often have a weakened skin barrier as well as an overactive immune response, so allergens penetrate the skin more easily and trigger ongoing inflammation. 7.2mg Numelvi Tablets are commonly considered when the main problem is persistent itch, because pruritus is often what drives further skin trauma. Typical signs of allergic dermatitis and atopic dermatitis can include:
- Dogs may scratch, rub or chew at the paws, face, ears, armpits, groin or abdomen.
- Dogs may develop red skin, saliva staining, hair loss, recurrent rashes or thickened skin.
- Dogs may also suffer recurrent otitis externa, secondary bacterial pyoderma or Malassezia overgrowth.
When these signs continue, dogs can become restless, sleep poorly and seem less settled at home. This is why 7.2mg Numelvi Tablets are usually used as part of a plan that also looks for the underlying trigger.
More Information
Description
Allergic skin disease is driven by signalling proteins called cytokines, which pass messages between immune cells and skin cells. Some of the most important itch and inflammation signals rely on the JAK-STAT pathway, especially JAK1 activity. Atinvicitinib in 7.2mg Numelvi Tablets is highly selective for JAK1, so it helps block the messages that tell the skin to itch and inflame. 7.2mg Numelvi Tablets reduce the intensity of the internal itch signal rather than simply coating the skin or masking discomfort from the outside. This targeted mechanism helps calm pruritus while still fitting into a broader diagnostic approach. Although owners often focus on scratching, vets also think about erythema, excoriations, self-trauma, recurrent ear disease and the risk of secondary infection. By reducing the signalling that fuels allergic itch, Numelvi Tablets can give the skin a better chance to recover and can make other supportive measures more effective.
7.2mg Numelvi Tablets are given by mouth once daily at or around feeding time, with the exact dose chosen according to bodyweight. The tablets are scored and can be divided into equal halves when a vet needs finer dose adjustment. It is also important to remember that controlling allergic dermatitis is not just about suppressing itch. If a dog has fleas, mites, a food reaction, bacterial folliculitis, yeast dermatitis or sore ears, those problems need identifying and treating as well. Your vet may combine 7.2mg Numelvi Tablets with parasite control, medicated shampoos, topical ear care, dietary trials or skin barrier support. Safety has not been fully established in dogs under 6 months of age, and the available strengths do not allow accurate dosing below 2kg bodyweight, so suitability must always be confirmed by a veterinary surgeon.
Chronic atopic dermatitis often needs longer-term management, because the disease itself is not cured by one medicine. Instead, 7.2mg Numelvi Tablets are used to control signs while the vet monitors flare-ups, response to treatment and any secondary complications. If a dog has repeated infections, persistent ear problems or poor response to standard treatment, further work-up may be needed. This can include parasite checks, cytology, elimination diet trials or allergy-focused investigations. 7.2mg Numelvi Tablets can play an important role by helping to stabilise the patient while the bigger dermatology picture is being addressed.
What are 7.2mg Numelvi Tablets used for in dogs?
Numelvi Tablets are used to treat itching, or pruritus, linked with allergic dermatitis in dogs. They are also used to manage the clinical signs of atopic dermatitis, a common long-term allergic skin disease. They should only be used under veterinary direction after the cause of the itch has been assessed.
How do Numelvi Tablets work?
7.2mg Numelvi Tablets contain atinvicitinib, a selective JAK1 inhibitor. JAK1 is involved in the signalling pathways that drive allergic itch and inflammation. By reducing those signals, the tablets help calm the urge to scratch, which can reduce self-trauma and give irritated skin a better chance to recover.
What is the difference between allergic dermatitis and atopic dermatitis in dogs?
Allergic dermatitis is a broad term for itchy inflammatory skin disease caused by an allergy. Atopic dermatitis is one specific type, usually linked to environmental allergens such as pollen or dust mites. Both can cause redness, scratching and recurrent skin problems, but atopic dermatitis is usually chronic and relapsing.
How quickly can 7.2mg Numelvi Tablets start to help?
Response times vary from dog to dog, but anti-itch treatment is usually prescribed because fast relief matters in allergic skin disease. Some dogs appear more comfortable early in treatment, while visible skin healing can take longer. Owners should still follow the full plan from their vet and not stop treatment prematurely.
What side effects can occur with 7.2mg Numelvi Tablets?
The more commonly discussed side effects include vomiting, diarrhoea, reduced appetite and lethargy. Many dogs take the medicine without major problems, but any ongoing digestive upset, unusual tiredness or worsening skin disease should be reported to your vet promptly so the treatment plan can be reviewed if needed.
You may also like
